COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpBehnood Bikdeli, Gregory Y.H. Lip, Jawed Fareed et al.|Journal of the American College of Cardiology|2020Cited by 2.9k
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated CoagulopathyJean‐Louis Vincent, Bruno François, И. Б. Заболотских et al.|JAMA|2019Cited by 370
A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*Jean‐Louis Vincent, Inder Kaul, M Ramesh et al.|Critical Care Medicine|2013Cited by 322
Increased Level of Thrombotic Biomarkers in Patients with Atrial Fibrillation Despite Traditional and New Anticoagulant TherapyJeffrey Liles, Jawed Fareed, Jordan Liles et al.|Clinical and Applied Thrombosis/Hemostasis|2016Cited by 19
Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint ArthroplastyChristopher Wanderling, Jawed Fareed, Jeffrey Liles et al.|Clinical and Applied Thrombosis/Hemostasis|2017Cited by 19